Therapy Dog Visits for Patients Hospitalized With Traumatic Injuries
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Sabrina Sanchez, MD MPH
- Phone Number: 617 414 4861
- Email: sabrina.sanchez@bmc.org
Study Contact Backup
- Name: Sara Myers, MD
- Phone Number: 617 638 9191
- Email: sara.myers@bmc.org
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Recruiting
- Boston Medical Center, Trauma Inpatient Service
-
Contact:
- Sara Myers, MD
- Phone Number: 617 638 9191
- Email: sara.myers@bmc.org
-
Contact:
- Sabrina Sanchez, MD MPH
- Phone Number: 617-414-4861
- Email: sabrina.sanchez@bmc.org
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients admitted to the Trauma and Acute Care Surgery (TACS) service following a trauma
- English or Spanish speaking
- Able to provide informed consent
Exclusion Criteria:
- Fear of dogs, allergy to dogs
- Immunocompromised
- Contact precautions
- Delirious, intubated, or otherwise unable to consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Therapy dog visits
Participants randomized into this arm will receive visits from a therapy dog and their handler during hospitalization.
|
2-3 ten-minute visits by a trained therapy dog and the dog's handler
|
|
Active Comparator: Dog handler visits
Participants randomized into this arm will receive visits from a dog handler during hospitalization.
|
2-3 ten-minute visits by a dog handler
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participants' pain assessed with a numeric analog score
Time Frame: 24 hours after the last study visit
|
The visual analog score ranges from 0 to 10 where 0= no pain and 10 worst pain (5= moderate pain).
|
24 hours after the last study visit
|
|
Participants' pain assessed with pictures of facial expressions
Time Frame: 24 hours after the last study visit
|
The 6 facial pictorial expressions range from 0 to 10 where 0 is a face with a broad smile and 10 is a very sad face with tears.
|
24 hours after the last study visit
|
|
Depression assessed by the Brief Mood Survey
Time Frame: 24 hours after the last study visit
|
There are 5 questions related to feeling depressed in the Brief Mood Survey with five potential responses of- 'Not at all', 'Somewhat', 'Moderately', 'A lot', and 'Extremely'.
The range of scores for each of the 5 questions is 0 to 4, with a summed total score of 0 to 20 for the domain and higher scores are associated with feeling more depressed.
|
24 hours after the last study visit
|
|
Anxiety assessed by the Brief Mood Survey
Time Frame: 24 hours after the last study visit
|
There are 5 questions related to feeling anxious in the Brief Mood Survey with five potential responses of- 'Not at all', 'Somewhat', 'Moderately', 'A lot', and 'Extremely'.
The range of scores for each of the 5 questions is 0 to 4, with a summed total score of 0 to 20 for the domain, and higher scores are associated with feeling more anxious.
|
24 hours after the last study visit
|
|
Anger assessed by the Brief Mood Survey
Time Frame: 24 hours after the last study visit
|
There are 5 questions related to feeling angry in the Brief Mood Survey with five potential responses of- 'Not at all', 'Somewhat', 'Moderately', 'A lot', and 'Extremely'.
The range of scores for each of the 5 questions is 0 to 4, with a summed total score of 0 to 20 for the domain, and higher scores are associated with feeling more angry.
|
24 hours after the last study visit
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Emotional quality of life now
Time Frame: 24 hours after the last study visit
|
The Emoqol-100 will be used to assess emotional quality of life.
It is one question, 'How is your emotional quality of life now, with 100 being perfect and 0 being the worst imaginable?' Higher numbers are associated with a better quality of life.
|
24 hours after the last study visit
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Sabrina Sanchez, MD MPH, Boston Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- H45457
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.